rs71651683

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000675.6(ADORA2A):​c.-274-246C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0331 in 159,674 control chromosomes in the GnomAD database, including 187 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.034 ( 187 hom., cov: 33)
Exomes 𝑓: 0.0085 ( 0 hom. )

Consequence

ADORA2A
NM_000675.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.450

Publications

9 publications found
Variant links:
Genes affected
ADORA2A (HGNC:263): (adenosine A2a receptor) This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor (GPCR) superfamily, which is subdivided into classes and subtypes. The receptors are seven-pass transmembrane proteins that respond to extracellular cues and activate intracellular signal transduction pathways. This protein, an adenosine receptor of A2A subtype, uses adenosine as the preferred endogenous agonist and preferentially interacts with the G(s) and G(olf) family of G proteins to increase intracellular cAMP levels. It plays an important role in many biological functions, such as cardiac rhythm and circulation, cerebral and renal blood flow, immune function, pain regulation, and sleep. It has been implicated in pathophysiological conditions such as inflammatory diseases and neurodegenerative disorders. Alternative splicing results in multiple transcript variants. A read-through transcript composed of the upstream SPECC1L (sperm antigen with calponin homology and coiled-coil domains 1-like) and ADORA2A (adenosine A2a receptor) gene sequence has been identified, but it is thought to be non-coding. [provided by RefSeq, Jun 2013]
SPECC1L-ADORA2A (HGNC:49185): (SPECC1L-ADORA2A readthrough (NMD candidate)) This locus represents naturally occurring readthrough transcription between the neighboring SPECC1L (sperm antigen with calponin homology and coiled-coil domains 1-like) and ADORA2A (adenosine A2a receptor) genes on chromosome 22. The readthrough transcript is a candidate for nonsense-mediated mRNA decay (NMD) and is unlikely to produce a protein product. [provided by RefSeq, Jun 2013]
ADORA2A-AS1 (HGNC:37122): (ADORA2A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0815 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADORA2ANM_000675.6 linkc.-274-246C>T intron_variant Intron 1 of 2 ENST00000337539.12 NP_000666.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADORA2AENST00000337539.12 linkc.-274-246C>T intron_variant Intron 1 of 2 1 NM_000675.6 ENSP00000336630.6 P29274
SPECC1L-ADORA2AENST00000358654.2 linkn.*862-246C>T intron_variant Intron 18 of 19 2 ENSP00000351480.2 F8WAN1

Frequencies

GnomAD3 genomes
AF:
0.0341
AC:
5195
AN:
152140
Hom.:
183
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0834
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0313
Gnomad ASJ
AF:
0.0308
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00435
Gnomad FIN
AF:
0.00791
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0144
Gnomad OTH
AF:
0.0297
GnomAD4 exome
AF:
0.00850
AC:
63
AN:
7416
Hom.:
0
Cov.:
0
AF XY:
0.00699
AC XY:
28
AN XY:
4008
show subpopulations
African (AFR)
AF:
0.0357
AC:
3
AN:
84
American (AMR)
AF:
0.00651
AC:
7
AN:
1076
Ashkenazi Jewish (ASJ)
AF:
0.0213
AC:
2
AN:
94
East Asian (EAS)
AF:
0.00
AC:
0
AN:
148
South Asian (SAS)
AF:
0.000911
AC:
1
AN:
1098
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
138
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
14
European-Non Finnish (NFE)
AF:
0.00967
AC:
43
AN:
4448
Other (OTH)
AF:
0.0222
AC:
7
AN:
316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0343
AC:
5221
AN:
152258
Hom.:
187
Cov.:
33
AF XY:
0.0330
AC XY:
2459
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0838
AC:
3484
AN:
41554
American (AMR)
AF:
0.0312
AC:
477
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0308
AC:
107
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00435
AC:
21
AN:
4828
European-Finnish (FIN)
AF:
0.00791
AC:
84
AN:
10614
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0144
AC:
979
AN:
68008
Other (OTH)
AF:
0.0294
AC:
62
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
243
485
728
970
1213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0209
Hom.:
112
Bravo
AF:
0.0386
Asia WGS
AF:
0.00635
AC:
22
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
5.3
DANN
Benign
0.94
PhyloP100
-0.45
PromoterAI
0.0035
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71651683; hg19: chr22-24828853; API